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Tramadol  is an  opioid  analgesic  used  to alleviate  acute  and  chronic  pain.  Nigella  sativa  oil  is
one  of the  traditional  remedies  with  antioxidant  activity.  This  study  was  designed  in  order
to investigate  the  ultrastructural  alterations  induced  by  tramadol  in  the  rat  cerebral  cor-
tex and  to ﬁnd  out  any  possible  protective  effect  of  N. sativa  oil  against  these  alterations.
Twenty-four  male albino  rats  were  assigned  to three  groups.  Group  I received  intraperi-
toneal  and  oral  normal  saline  for  30 days.  Group  II received  intraperitoneal  injections  of
tramadol  20  mg/kg/day,  40 mg/kg/day  and  80 mg/kg/day  on the  ﬁrst,  second  and  third  10
days  of  the  study,  respectively.  Group  III received  intraperitoneal  tramadol  similar  to Group
II  and  oral  N. sativa  oil  at a dose  of 4 ml/kg/day  for 30 days.  Specimens  from  the motor
area  were  obtained  and  processed  for transmission  electron  microscopy.  In the  tramadol-
treated  group,  pyramidal  and  granular  cells  appeared  shrunken  and  showed  ultrastructural
features  of  apoptosis  such  as nuclear  membrane  invaginations,  chromatin  margination,
dilated  rough  endoplasmic  reticulum,  dilated  Golgi  saccules,  and mitochondria  with  disin-
tegrated  cristae.  The  myelinated  axons  showed  disorganization  and  splitting  of  the  myelin
sheath and  contained  vacuoles  and  abnormal  mitochondria.  Administration  of N.  sativa oil
partially protected  the  cortical  neurons  and  myelinated  axons  against  tramadol-induced
changes.  In conclusion,  N. sativa  oil  alleviates  ultrastructural  apoptotic  changes  induced  by
tramadol  in  the  rat  motor  cerebral  cortex.
©  2015  Saudi  Society  of  Microscopes.  Published  by Elsevier  Ltd.  All  rights  reserved.1. Introduction
The opioid analgesic tramadol has been used to alleviate
acute and chronic pain [1]. It has been prescribed in many
pathological conditions, for example, motor neuron dis-
ease, rheumatoid arthritis and management of labor pain
[2].
The structure of tramadol is similar to codeine and
has analgesic potency lower than that of morphine [3].
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Therefore, it is effective in the treatment of depression, anx-
iety and phobias [4,5]. Various tramadol adverse reactions
such as nausea, vomiting, sweating, itching, constipa-
tion and psychological and physical addiction have been
reported [6,7].
In Arabian countries, Nigella sativa is commonly
used as traditional medicine for treatment of many
pathological conditions [8]. N. sativa has immunomodula-
tory, anti-inﬂammatory and antihistaminic effects [9,10].
Antioxidant and anti-eicosanoid activities of the ﬁxed oil
of N. sativa have been previously described [11]. Most of
the biological activity of N. sativa has been found to be
due to thymoquinone, which is a pharmacologically active
ghts reserved.
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Figure 1. A semithin section of control rat cerebral cortex showing pyra-
midal cells (arrows), apical dendrite (arrowhead), perineural neuroglia
(crossed arrows), and myelinated axons (tailed arrows). Stain: toluidine
blue; magniﬁcation: 1000×.
Figure 2. Electron micrographs of the cerebral cortex of control rat. (a,b) a pyram
dendrite (D), mitochondria (m), rER (arrowheads), Golgi saccules (tailed arrows)
axons (arrows). (c, d) A granular cell (G) with highly vesicular nucleus (N), mito
saccules (tailed arrow). Magniﬁcation: a, c, 1500×; b, d, 2500×.Ultrastructure 4 (2016) 76–84 77
quinone and has analgesic and anti-inﬂammatory activities
[12].
The effect of tramadol on the cerebral cortex has
been previously investigated; however, few studies have
demonstrated its effect on the ultrastructure of the rat
motor cortex. Therefore, this study was  designed to demon-
strate the ultrastructural alterations caused by tramadol
in the rat cerebral cortex and to investigate whether or
not treatment with N. sativa oil (NSO) could alleviate such
changes.×
2. Materials and methods
2.1. ChemicalsTramadol hydrochloride was obtained from (ADWIA,
Ramadan City, Egypt) as 20-mg ampoules. N. sativa extract
volatile oil was  purchased from Pharco (Alexandria, Egypt)
as 100-mg capsules.
idal cell with a vesicular nucleus (N), prominent nucleolus (Nu), apical
 and a lysosome (crossed arrow). Note also neuropil (*) and myelinated
chondria (m), rER (arrowheads), lysosomes (crossed arrows) and Golgi
opy and Ultrastructure 4 (2016) 76–84
Figure 3. An electron micrograph of control rat cerebral cortex showing a
myelinated axon with a smooth regular contour and regular arrangement
of myelin lamellae (arrows). The axoplasm contains a mitochondrion (m)
signiﬁcant.78 N.M. Omar / Journal of Microsc
2.2. Animals
The experimental protocol of the study was designed
according to the rules approved by the Ethical Commit-
tee of the Faculty of Medicine, Mansoura University, Egypt.
Animals were maintained and used in accordance with the
Animal Welfare Act and the Guide for the Care and Use of
MERC (Mansoura Experimental Research Center). Twenty-
four male albino rats of average weight 180–220 g were
kept in an adequately ventilated room at 22 ◦C and 25 ◦C,
under a regular 12-hour light/12-hour dark cycle and given
food and water ad libitum.
2.3. Animal grouping
The animals were randomly assigned to three equal
groups. Group I (control group) received normal intraperi-
toneal and oral saline for 30 days. Group II (tramadol-
treated group) received repeated intraperitoneal injec-
tions of increasing doses of tramadol of 20 mg/kg/day,
40 mg/kg/day and 80 mg/kg/day on the ﬁrst, second, and
third 10 days of the study, respectively. The dose of tra-
madol was equivalent to that used in a previous study [13].
Group III (tramadol + NS-treated group) received intraperi-
toneal tramadol at doses similar to those of Group II. In
addition, N. sativa extract volatile oil was administered
orally at a dose of 4 ml/kg/day, 30 minutes before each tra-
madol injection for 30 days. The dose of the oil was  detected
in accordance with a previous work [14].
2.4. Histological study
All animals were anesthetized using intraperitoneal
sodium pentobarbital (40 mg/kg). Animal perfusion was
done through the left ventricle. Small fragments (1 mm3)
from the left motor area were rapidly obtained and
immediately ﬁxed in 0.1 mol/L phosphate buffer con-
taining 2.5% glutaraldehyde and 2% paraformaldehyde at
4 ◦C overnight. Specimens were postﬁxed in 1% osmium
tetroxide for 1 hour at 4 ◦C and washed three times in
phosphate-buffered saline (10 minutes each). Specimens
were dehydrated in graded ethanol and cleared in ace-
tone. The specimens were immersed in equal volumes of
Epon and acetone for 1 hour, followed by acetone: Epon
(25:50) for 1 hour. Finally, the specimens were immersed
in Epon only in embedding capsules and placed in the
oven at 60 ◦C overnight for polymerization. Semithin sec-
tions (1 m)  were cut by ultramicrotome (Ultracut UCT;
Leica, Germany) and stained with 1% toluidine blue. Ultra-
thin sections (60–80 nm)  were cut and stained with 2%
uranyl acetate for 10 minutes, followed by Reynold’s lead
citrate for 10 minutes. Ultrathin sections were examined
and photographed using a JEOL-JEM-100 SX transmission
electron microscope [15] in the Electron Microscopy Unit,
Tanta University, Egypt.
2.5. Statistical analysisUsing the semithin sections, shrunken pyramidal cells
were counted in 10 high-power ﬁelds (1000 × ) for each
group. To assess the degree of axon circularity, 10 axonsand neuroﬁbrils (arrowheads). Magniﬁcation: 20,000×.
from electron micrographs of each group were manually
extracted and index of circularity (IC) for the myelin-
ated axons was measured using Image J software. IC
was  calculated as the ratio between the surface area of
the myelinated axon and the area of a circle having the
same perimeter [16]. The collected data were analyzed
using SPSS version 16. Student’s t test was used to com-
pare the studied groups. The results were presented as
mean ± standard deviation and p ≤ 0.05 was  consideredFigure 4. A semithin section of tramadol-treated rat cerebral cortex
showing shrunken pyramidal cells (arrows), perineural neuroglia (crossed
arrow) and dilated capillaries (wavy arrows). Note ill-deﬁned myelinated
axons in the neuropil (*). Stain: toluidine blue; magniﬁcation: 1000×.
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Figure 5. Electron micrographs of Tramadol-treated rat cerebral cortex. (a) Shrunken pyramidal cell with a wide perineural space (arrows), nucleus (N),
nucleolus (Nu), chromatin margination (curved arrows) and dilated rER (arrowheads). Note irregular outline of myelinated axons (tailed arrows) in the
neuropil (*). (b) Apoptotic pyramidal cell (p) with wide perineural space (crossed arrows), nucleus (N), wide perinuclear space (arrows), nuclear membrane
invaginations (tailed arrows), chromatin margination (curved arrows) and dilated rER (arrowhead). A perineural neuroglia (g) shows a hyperchromatic
nucleus (N), wide perinuclear space (wavy arrows), a lysosome (crossed arrow) and a large cytoplasmic vacuole (v). (c) Degenerated pyramidal cell with
complete loss of cytoarchitecture. The cytoplasm appears dense and shows many lysosomes (crossed arrows), mitochondria with disintegrated cristae
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rrow), clumps of marginated chromatin (curved arrows), mitochondri
accules (arrows). Magniﬁcation: a, d, 1500×; b, 2000×; c, 2500×.
. Results
.1. Histological results
.1.1. Control group
Examination of semithin sections of control rat motor
ortex demonstrated the inner pyramidal layer contain-
ng large pyramidal cells scattered in a background of
euroglia formed of neuroglia cells and myelinated axons
Figure 1). By electron microscopy, the pyramidal cells
ere characterized by vesicular nuclei with prominent
ucleoli and apical dendrites (Figure 2a). The cytoplasm
howed rough endoplasmic reticulum (rER), mitochon-
ria, lysosomes and Golgi apparatus (Figure 2b). Granularnular cell showing a nucleus (N), nuclear membrane invagination (tailed
sosomes (crossed arrows), dilated rER (arrowheads) and dilated Golgi
cells were also demonstrated. They appeared rounded with
highly vesicular rounded nuclei (Figure 2c). The cytoplasm
contained rER, ribosomes, mitochondria, Golgi apparatus
and lysosomes (Figure 2d). The myelinated axons showed
smooth regular contours and regular arrangement of the
myelin lamellae and the axoplasm contained mitochondria
and neuroﬁbrils (Figure 3).
3.1.2. Tramadol-treated group
Examination of semithin sections of tramadol-treatedrat motor cortex revealed shrunken pyramidal cells, per-
ineural neuroglia, dilated blood capillaries and ill-deﬁned
myelinated axons (Figure 4). In the ultrathin sections,
pyramidal cells appeared shrunken with wide perineural
80 N.M. Omar / Journal of Microscopy and Ultrastructure 4 (2016) 76–84
Figure 6. Electron micrographs of tramadol-treated rat cerebral cortex showing two myelinated axons (arrows). (a) Splitting (arrowheads) of myelin
mic vac
, 15,000
II (p < 0.01), however, it was  still higher than in the Control
Group (Figure 11). IC was signiﬁcantly decreased (p < 0.01)
in Group II compared to Groups I and III (Figure 12).lamellae, swollen mitochondria (m)  with disrupted cristae and a cytoplas
myelin sheath, mitochondria (m)  and a large vacuole (v). Magniﬁcation: a
spaces. The nuclei showed nuclear membrane invagina-
tions and margination of chromatin and the cytoplasm
contained dilated rER (Figures 5a and 5b). The perineu-
ral neuroglia also showed nuclear condensation with
wide perinuclear spaces, lysosomes and cytoplasmic vac-
uoles (Figure 5b). Some of the pyramidal cells appeared
degenerated with complete loss of cytoarchitecture. The
cytoplasm appeared dense and contained many lyso-
somes, vesiculated and dilated Golgi saccules, and damaged
mitochondria (Figure 5c). The granular cells were also
shrunken and showed invagination of the nuclear mem-
brane and clumps of marginated chromatin. The cytoplasm
contained many lysosomes, dilated rER and dilated Golgi
saccules (Figure 5d). The myelinated axons were irregular
in outline and showed splitting or discontinuity of myelin
sheaths. The axoplasm contained vacuoles and mitochon-
dria with disrupted cristae (Figures 5a and 6).
3.1.3. Tramadol + NS-treated group
In the semithin sections, the motor cortex of this group
showed apparently normal pyramidal cells, however, few
degenerated pyramidal cells were seen (Figure 7). The
ultrastructural study revealed that most of the pyrami-
dal cells were similar to the control group with vesicular
nuclei and prominent nucleoli. The cytoplasm contained
well-developed rER, numerous ribosomes, lysosomes,
well-developed Golgi, and intact elongated mitochondria
(Figures 8a and 8b). However, occasional degenerated
pyramidal cells with dark folded nuclei, dilated rER, lyso-
somes and dilated Golgi saccules were still demonstrated
(Figure 8c). The granular cells appeared normal and had
similar structure to the control group. The nuclei were
highly vesicular with regular contours and the cytoplasm
showed a well-developed rER, numerous ribosomes, intact
rounded and elongated mitochondria, lysosomes and Golgi
apparatus (Figure 9). Myelinated axons appeared similar touole (v). (b) Irregular outline with focal interruption (crossed arrows) of
×; b, 10,000×.
those in the control group with smooth regular contours
and regular arrangement of myelin lamellae. However,
focal splitting of myelin sheaths and damaged mitochon-
dria were still observed (Figure 10).
3.2. Statistical analysis
The mean number of shrunken pyramidal cells/high-
power ﬁeld was  signiﬁcantly increased in Group II
compared to the Control Group (p < 0.001). This number
was  signiﬁcantly decreased in Group III compared to GroupFigure 7. A semithin section of tramadol + NS-treated rat cerebral cor-
tex showing an apparently normal pyramidal cell (arrow), a shrunken
pyramidal cell (curved arrow), a perineural neuroglia (crossed arrow) and
myelinated axons (tailed arrows). Stain: toluidine blue; magniﬁcation:
1000×.
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4. Discussion
The tramadol-treated group had degenerated shrunken
neurons and neurons with ultrastructural features of
apoptotic cell death in the form of nuclear invagination,
chromatin margination, dilated rER cisternae, and abnor-
mal  mitochondria. It has been reported that early-phase
apoptosis is characterized by invagination of the nuclear
membrane. In the late phase, the chromatin becomes con-
densed and segregated along the margin of the nuclear
membrane, and the cytoplasm shows densely packed
organelles, including mitochondria and electron-dense
vesicles [17]. Similar ultrastructural changes indicating
apoptosis were observed in the brain of monkeys and rats
with drug-induced and septic neurotoxicity [18,19]. Red
neuron degeneration and apoptosis were also found in the
brains of rats with chronic use of morphine and opioids
[13,20].
Abnormal mitochondria were also observed in the
neurons and axons of the tramadol-treated group. The
mitochondrial changes observed in this study may be an
early sign of apoptosis and a mechanism by which the
cell adapts to an unfavorable environment, such as free
radicals [21]. High doses of tramadol inhibit Complexes
I, III and IV of the electron transfer chain in mitochon-
dria. The inhibition of Complex III leads to generation of
reactive oxygen species [22]. The decrease in the mitochon-
drial membrane potential following mitochondrial damage
leads to release of apoptosis-inducing factors, resulting in
activation of caspase proteases that cause nuclear conden-
sation and cytoplasmic fragmentation [23].
Tramadol administration induces oxidative stress and
a signiﬁcant decrease in the antioxidants in brain tissue
[14,24]. Also, tramadol induces inﬂammatory reactions
that may  be the cause of oxidative stress by changing cell
membrane fatty acid composition [25]. The brain is highly
susceptible to oxidative damage because it has high oxygen
consumption, high concentration of polyunsaturated fatty
acids and low levels of antioxidants [26]. Oxidative stress
causes protein modiﬁcations and carbonylation that result
in loss of function and decrease of enzyme activity [27].
NO appears to be involved in the analgesic effect of
tramadol [28]. The reaction between NO and superoxide
results in peroxynitrite, which exerts its toxic effect via
direct oxidative mechanisms [29]. Nitration of structural
proteins such as neuroﬁlaments and actin can disrupt ﬁla-
ment assembly and induce pathological consequences [30].
Similarly, long-term use of opioids can affect the neuronal
cytoskeleton and induce neuronal damage [31]. More-
over, splitting and irregular contours of myelin reported in
tramadol-treated rats can be explained by myelin damage
Figure 8. Electron micrographs of the cerebral cortex of tramadol + NS-
treated rat. (a, b) Pyramidal cell with vesicular nucleus (N), prominent
nucleolus (Nu) and apical dendrite (D), intact elongated mitochondria
(m), rER (arrowheads), numerous ribosomes (curved arrows), a well-
developed Golgi apparatus (tailed arrow) and lysosomes (crossed arrow).
(c)  Shrunken pyramidal cell showing dark highly folded nucleus (N),
dilated rER (arrowheads), dilated Golgi saccules (tailed arrows), lyso-
somes (crossed arrows) and mitochondria (m) with mild cristolysis.
Magniﬁcation: a, 2000×; b, 4000×; c, 2500×.
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tramado
erous ri
induced by free radical generating pathology, as previ-
ously described [34,35]. It is reported that N. sativa oil
possesses anti-inﬂammatory and immunomodulatory andFigure 9. Electron micrographs of a granular cell in the cerebral cortex of 
elongated intact mitochondria (m), well developed rER (arrowheads), num
a,  1500×; b, 2500×.
caused by NO, decreased myelin-associated glycoprotein,
or autoantibodies to myelin basic protein [32]. In addition,
tramadol may  affect the vascular endothelial cells, result-
ing in NO release, which has an endothelium-relaxing effect
leading to vascular congestion, as observed in the cerebral
cortex of tramadol-treated rats [33].
Marked reduction of ultrastructural apoptotic changes
was observed in the cerebral cortex of Tramadol + NS-
treated rats. Most neurons and axons appeared normal
with intact mitochondria and rER. These ﬁndings indicate
Figure 10. An electron micrograph of tramadol + NS-treated rat cerebral
cortex showing two myelinated axons (arrows). Myelin sheaths appear
intact except for areas of focal splitting (arrowheads) of myelin lamellae,
the mitochondria are either intact (tailed arrow) or disrupted (crossed
arrow). Magniﬁcation: 20,000×.l + NS-treated rat showing highly vesicular nucleus (N), many rounded or
bosomes (curved arrows) and a lysosome (crossed arrow). Magniﬁcation:
a protective effect of N. sativa oil against tramadol-induced
cellular damage. This improvement may  be due to the pro-
tective role of thymoquinone against oxidative damageFigure 11. Mean number of shrunken pyramidal cells/high-power ﬁeld
in  studied groups.
Figure 12. Mean index of circularity in studied groups.
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ntioxidant properties and thus decreases the oxidative
tress caused by drugs and heavy metals [36,37]. More-
ver, a protective role of thymoquinine against oxidative
tress was also demonstrated in hippocampal neurodegen-
ration after chronic toluene exposure and in rat models
f cerebral ischemia–reperfusion injury and subarachnoid
emorrhage [34,38,39]. The antioxidant activity of thy-
oquinone is due to inhibition of eicosanoid generation,
amely thromboxane B2 and leukotriene B4 and could pre-
ent membrane lipid peroxidation in the tissues [38,40].
n addition, N. sativa could inhibit NO production and
xpression of inducible NO synthase [41,42], which may  be
rucial mechanisms by which N. sativa oil protects against
azardous effects of tramadol on the cerebral cortex. In
onclusion, tramadol administration results in many apop-
otic ultrastructural changes in the cerebral cortex, which
re markedly ameliorated by N. sativa oil.
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